Related Experiment Video
Updated: Apr 9, 2026
04:48
Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair
Published on: March 1, 2024
2.5K
Human Gingival Integration-Free iPSCs; a Source for MSC-Like Cells
Yasuyuki Umezaki1, Yoshiya Hashimoto2, Naoki Nishishita3
1Department of Oral Implantology, Osaka Dental University, Hirakata, Osaka 573-1121, Japan. umezaki@cc.osaka-dent.ac.jp.
International Journal of Molecular Sciences
|June 18, 2015
Summary
Human gingival cells can be reprogrammed into integration-free induced pluripotent stem cells (iPSCs). These iPSCs can then be differentiated into mesenchymal stem-like cells (MSLCs) for tissue regeneration applications.
Area of Science:
- Stem Cell Biology
- Tissue Engineering
- Regenerative Medicine
Background:
- Mesenchymal stem cells (MSCs) are crucial for tissue engineering but are limited by invasive retrieval and restricted proliferation.
- An accessible and safe alternative source of MSCs is needed for effective autologous therapies.
Purpose of the Study:
- To generate integration-free induced pluripotent stem cells (iPSCs) from an easily accessible human tissue source.
- To differentiate these iPSCs into mesenchymal stem-like cells (MSLCs) for potential autologous tissue engineering.
Main Methods:
- Human gingival tissues were used to derive iPSCs via non-integrating episomal plasmids.
- Established iPSCs were characterized for pluripotency markers and differentiation potential.
- iPSCs were differentiated into MSLCs and assessed for trilineage differentiation capacity.
Main Results:
- Integration-free iPSCs were successfully generated from human gingival tissue.
- These iPSCs expressed embryonic stem cell markers and formed embryoid bodies and teratomas.
- Differentiated iPSCs exhibited MSLC characteristics and trilineage differentiation potential.
Conclusions:
- Human gingival integration-free iPSCs represent a promising, accessible stem cell source.
- Episomal plasmid-derived iPSCs can be differentiated into functional MSLCs.
- This approach offers a viable strategy for autologous tissue regeneration.
Related Concept Videos
01:22iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
01:13Induced Pluripotent Stem Cells
28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
01:06Induced Pluripotent Stem Cells
6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.3K